超导管大动脉替换退行性生物假体马赛克门
Vaibhav J Bhastana1, Swaroop G Bharadi1, Rajeev V Menon1
1Department of Cardiology, Asian Institute of Gastroenterology Hospitals, Hyderabad, Telangana, India.
JACC. Case reports
|February 18, 2025
概括
门置换中的透气管大动脉是手术门失效的有效治疗方法. 这一案例凸显了在手术过程中栓塞的罕见并发症及其成功管理.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 穿通管的大动脉内 (TAV-in-V) 是对失败的生物假体进行重复手术的替代方案.
- 重制心脏手术带有高发病率和死亡率的风险.
- 一般来说,TAV-in-V是有效的,但存在潜在的安全问题.
研究的目的:
- 在TAV-in-V期间呈现罕见的栓栓塞病例.
- 描述这种特定并发症的管理方法.
- 为了增加对TAV-in-V安全和程序性挑战的理解.
主要方法:
- 关于TAV-in-V并发症的文献审查.
- 一个患者经历了栓栓塞的详细病例报告.
- 描述为管理所采取的干预和手术步骤.
主要成果:
- 由于位置错误,TAV-in-V程序因设备栓塞而复杂.
- 设备的成功检索和重新定位已经实现.
- 患者在干预后取得了良好的结果.
结论:
- 膜栓塞是TAV-in-V的罕见但严重的并发症.
- 及时识别和适当的管理对于患者的治疗结果至关重要.
- 谨慎的设备部署至关重要,以最大限度地降低TAV-in-V程序中的风险.
相关概念视频
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Valve Prolapse III: Nursing Management
586
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
586
Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598


